These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 36223599

  • 1. The cost-effectiveness of transvaginal hydrolaparoscopy versus hysterosalpingography in the work-up for subfertility.
    van Kessel MA, Pham CT, Tros R, Oosterhuis GJE, Kuchenbecker WKH, Bongers MY, Mol BWJ, Koks CAM.
    Hum Reprod; 2022 Nov 24; 37(12):2768-2776. PubMed ID: 36223599
    [Abstract] [Full Text] [Related]

  • 2. Hysterosalpingo-foam sonography versus hysterosalpingography during fertility work-up: an economic evaluation alongside a randomized controlled trial.
    Kamphuis D, van Eekelen R, van Welie N, Dreyer K, van Rijswijk J, van Hooff MHA, de Bruin JP, Verhoeve HR, Mol F, van Baal WM, Traas MAF, van Peperstraten AM, Manger AP, Gianotten J, de Koning CH, Koning AMH, Bayram N, van der Ham DP, Vrouenraets FPJM, Kalafusova M, van de Laar BIG, Kaijser J, Lambeek AF, Meijer WJ, Broekmans FJM, Valkenburg O, van der Voet LF, van Disseldorp J, Lambers MJ, Tros R, Lambalk CB, Stoker J, van Wely M, Bossuyt PMM, Mol BWJ, Mijatovic V.
    Hum Reprod; 2024 Jun 03; 39(6):1222-1230. PubMed ID: 38600625
    [Abstract] [Full Text] [Related]

  • 3. Can hysterosalpingo-foam sonography replace hysterosalpingography as first-choice tubal patency test? A randomized non-inferiority trial.
    van Welie N, van Rijswijk J, Dreyer K, van Hooff MHA, de Bruin JP, Verhoeve HR, Mol F, van Baal WM, Traas MAF, van Peperstraten AM, Manger AP, Gianotten J, de Koning CH, Koning AMH, Bayram N, van der Ham DP, Vrouenraets FPJM, Kalafusova M, van de Laar BIG, Kaijser J, Lambeek AF, Meijer WJ, Broekmans FJM, Valkenburg O, van der Voet LF, van Disseldorp J, Lambers MJ, Tros R, Lambalk CB, Stoker J, van Wely M, Bossuyt PMM, Mol BWJ, Mijatovic V.
    Hum Reprod; 2022 May 03; 37(5):969-979. PubMed ID: 35220432
    [Abstract] [Full Text] [Related]

  • 4. The effect of prior hysterosalpingo-foam sonography or hysterosalpingography on tubal patency: a secondary analysis of a randomized controlled trial.
    Kamphuis D, van Welie N, van Rijswijk J, van Hooff MHA, de Bruin JP, Verhoeve HR, Mol F, van Baal WM, Lambalk CB, Stoker J, van Wely M, Bossuyt PMM, Mol BWJ, Dreyer K, Mijatovic V, FOAM study group .
    Hum Reprod; 2024 Nov 01; 39(11):2485-2490. PubMed ID: 39190881
    [Abstract] [Full Text] [Related]

  • 5. Transvaginal hydrolaparoscopy versus hysterosalpingography in the work-up for subfertility: a randomized controlled trial.
    van Kessel M, Tros R, van Kuijk S, Oosterhuis J, Kuchenbecker W, Bongers M, Mol BW, Koks C.
    Reprod Biomed Online; 2021 Aug 01; 43(2):239-245. PubMed ID: 34253451
    [Abstract] [Full Text] [Related]

  • 6. The capacity of transvaginal hydrolaparoscopy versus hysterosalpingography to diagnose tubal pathology in the work-up of subfertile women, a randomised clinical trial.
    Tros R, van Kessel MA, van Kuijk SMJ, Oosterhuis GJE, Kuchenbecker WKH, Kwee J, Bongers MY, Mol BWJ, Koks CAM.
    Eur J Obstet Gynecol Reprod Biol; 2019 May 01; 236():127-132. PubMed ID: 30903885
    [Abstract] [Full Text] [Related]

  • 7. Fertility-related quality of life in subfertile women undergoing tubal testing with transvaginal hydrolaparoscopy or hysterosalpingography.
    van Kessel MA, Paulussen M, Tros R, Bongers MY, Mol BWJ, Koks CAM.
    Eur J Obstet Gynecol Reprod Biol; 2022 Jul 01; 274():19-22. PubMed ID: 35561566
    [Abstract] [Full Text] [Related]

  • 8. Thyroid function in neonates conceived after hysterosalpingography with iodinated contrast.
    van Welie N, Roest I, Portela M, van Rijswijk J, Koks C, Lambalk CB, Dreyer K, Mol BWJ, Finken MJJ, Mijatovic V, H2Oil Study Group.
    Hum Reprod; 2020 May 01; 35(5):1159-1167. PubMed ID: 32427280
    [Abstract] [Full Text] [Related]

  • 9. The FOAM study: is Hysterosalpingo foam sonography (HyFoSy) a cost-effective alternative for hysterosalpingography (HSG) in assessing tubal patency in subfertile women? Study protocol for a randomized controlled trial.
    van Rijswijk J, van Welie N, Dreyer K, van Hooff MHA, de Bruin JP, Verhoeve HR, Mol F, Kleiman-Broeze KA, Traas MAF, Muijsers GJJM, Manger AP, Gianotten J, de Koning CH, Koning AMH, Bayram N, van der Ham DP, Vrouenraets FPJM, Kalafusova M, van de Laar BIG, Kaijser J, van Oostwaard MF, Meijer WJ, Broekmans FJM, Valkenburg O, van der Voet LF, van Disseldorp J, Lambers MJ, Peters HE, Lier MCI, Lambalk CB, van Wely M, Bossuyt PMM, Stoker J, van der Veen F, Mol BWJ, Mijatovic V.
    BMC Womens Health; 2018 May 09; 18(1):64. PubMed ID: 29743106
    [Abstract] [Full Text] [Related]

  • 10. Neurodevelopmental outcomes of school-age children conceived after hysterosalpingography with oil-based or water-based iodinated contrast: long-term follow-up of a nationwide randomized controlled trial.
    Keestra SM, Van Welie N, Dreyer K, Van Eekelen R, Roseboom TJ, Oosterlaan J, Mol BW, Finken MJJ, Mijatovic V, Königs M.
    Hum Reprod; 2024 Oct 01; 39(10):2287-2296. PubMed ID: 39198011
    [Abstract] [Full Text] [Related]

  • 11. Does the effectiveness of IUI in couples with unexplained subfertility depend on their prognosis of natural conception? A replication of the H2Oil study.
    van Eekelen R, Rosielle K, van Welie N, Dreyer K, van Wely M, Mol BW, Eijkemans MJ, Mijatovic V, van Geloven N.
    Hum Reprod Open; 2020 Oct 01; 2020(4):hoaa047. PubMed ID: 33598567
    [Abstract] [Full Text] [Related]

  • 12. Treatment effect of oil-based contrast is related to experienced pain at HSG: a post-hoc analysis of the randomised H2Oil study.
    van Welie N, Dreyer K, van Rijswijk J, Verhoeve HR, Goddijn M, Nap AW, Smeenk JMJ, Traas MAF, Rijnsaardt-Lukassen HGM, van Dongen AJCM, Bourdrez P, de Bruin JP, Sluijmer AV, Gijsen AP, van de Ven PM, Lambalk CB, Mijatovic V, Mol BWJ.
    Hum Reprod; 2019 Dec 01; 34(12):2391-2398. PubMed ID: 31887222
    [Abstract] [Full Text] [Related]

  • 13. Tubal flushing with oil- or water-based contrast medium: can we identify markers that indicate treatment benefit?
    van Rijswijk J, van Welie N, Dreyer K, Tajik P, Lambalk CB, Hompes P, Mijatovic V, Mol BWJ, Zafarmand MH.
    Hum Reprod Open; 2019 Dec 01; 2019(3):hoz015. PubMed ID: 31334364
    [Abstract] [Full Text] [Related]

  • 14. No pain relief by virtual reality during hysterosalpingography (HSG): results from a randomized controlled trial.
    Rosielle K, van Haaps AP, Kuijper EAM, Tonch N, Karim DENB, Oskam MA, van den IJssel R, Mol BWJ, Lambalk CB, Dreyer K, Mijatovic V.
    Hum Reprod; 2024 Sep 01; 39(9):1987-1995. PubMed ID: 38863305
    [Abstract] [Full Text] [Related]

  • 15. Performance of outpatient transvaginal hydrolaparoscopy.
    Coenders-Tros R, van Kessel MA, Vernooij MM, Oosterhuis GJ, Kuchenbecker WK, Mol BW, Koks CA.
    Hum Reprod; 2016 Oct 01; 31(10):2285-91. PubMed ID: 27343269
    [Abstract] [Full Text] [Related]

  • 16. Gonadotrophins versus clomiphene citrate with or without IUI in women with normogonadotropic anovulation and clomiphene failure: a cost-effectiveness analysis.
    Bordewijk EM, Weiss NS, Nahuis MJ, Bayram N, van Hooff MHA, Boks DES, Perquin DAM, Janssen CAH, van Golde RJT, Lambalk CB, Goddijn M, Hompes PG, van der Veen F, Mol BWJ, van Wely M, M-ovin study group.
    Hum Reprod; 2019 Feb 01; 34(2):276-284. PubMed ID: 30576539
    [Abstract] [Full Text] [Related]

  • 17. Expectant management versus IUI in unexplained subfertility and a poor pregnancy prognosis (EXIUI study): a randomized controlled trial.
    Wessel JA, Mochtar MH, Besselink DE, Betjes H, de Bruin JP, Cantineau AEP, Groenewoud ER, Hooker AB, Lambalk CB, Kwee J, Kaaijk EM, Louwé LA, Maas JWM, Mol BWJ, van Rumste MME, Traas MAF, Goddijn M, van Wely M, Mol F.
    Hum Reprod; 2022 Nov 24; 37(12):2808-2816. PubMed ID: 36331493
    [Abstract] [Full Text] [Related]

  • 18. Birthweight and other perinatal outcomes of singletons conceived after assisted reproduction compared to natural conceived singletons in couples with unexplained subfertility: follow-up of two randomized clinical trials.
    Wessel JA, Mol F, Danhof NA, Bensdorp AJ, Tjon-Kon Fat RI, Broekmans FJM, Hoek A, Mol BWJ, Mochtar MH, van Wely M, INeS and SUPER Study Group.
    Hum Reprod; 2021 Feb 18; 36(3):817-825. PubMed ID: 33347597
    [Abstract] [Full Text] [Related]

  • 19. Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility.
    van Eekelen R, Wang R, Danhof NA, Mol F, Mochtar M, Mol BW, van Wely M.
    Hum Reprod; 2021 Apr 20; 36(5):1288-1295. PubMed ID: 33615360
    [Abstract] [Full Text] [Related]

  • 20. Cost-effectiveness of medically assisted reproduction or expectant management for unexplained subfertility: when to start treatment?
    van Eekelen R, Eijkemans MJ, Mochtar M, Mol F, Mol BW, Groen H, van Wely M.
    Hum Reprod; 2020 Sep 02; 35(9):2037-2046,. PubMed ID: 32876323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.